免疫相关不良事件（irAEs）对临床疗效具有预测作用：聚焦器官特异性irAEs及类固醇的关键作用 - Suppr

Immune-Related Adverse Events (irAEs) Predict for Clinical Efficacy: Focusing on Organ-Specific irAEs and the Critical Role of Steroids.

作者信息

Yang Xu, Lin Jianzhen, Wang Dongxu, Zhang Li, Zhao Haitao

机构信息

Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

Department of Respiratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

出版信息

J Thorac Oncol. 2019 Oct;14(10):e233-e234. doi: 10.1016/j.jtho.2019.05.020.

DOI:10.1016/j.jtho.2019.05.020

PMID:31558237

Abstract

摘要

相似文献

J Thorac Oncol. 2019 Oct;14(10):e233-e234. doi: 10.1016/j.jtho.2019.05.020.

In Response to the Letter by Dr. Yang et al, Immune-Related Adverse Events (irAEs) Predict for Clinical Efficacy: Forcing on Organ-Specific irAEs and the Critical Role of Steroids.

J Thorac Oncol. 2019 Nov;14(11):e260-e261. doi: 10.1016/j.jtho.2019.07.029.

BMC Cancer. 2019 Jun 10;19(1):558. doi: 10.1186/s12885-019-5701-6.

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients.

Clin Lung Cancer. 2019 Jul;20(4):237-247.e1. doi: 10.1016/j.cllc.2019.02.006. Epub 2019 Feb 21.

Predictors of immunotherapy-induced immune-related adverse events.

Curr Oncol. 2018 Oct;25(5):e403-e410. doi: 10.3747/co.25.4047. Epub 2018 Oct 31.

Influenza vaccination in patients with lung cancer receiving anti-programmed death receptor 1 immunotherapy does not induce immune-related adverse events.

Eur J Cancer. 2018 Nov;104:182-187. doi: 10.1016/j.ejca.2018.09.012. Epub 2018 Oct 24.

J Thorac Oncol. 2017 Dec;12(12):1798-1805. doi: 10.1016/j.jtho.2017.08.022. Epub 2017 Sep 20.

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study.

Lancet Haematol. 2019 Jan;6(1):e48-e57. doi: 10.1016/S2352-3026(18)30175-3. Epub 2018 Dec 4.

Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer.

Clin Lung Cancer. 2019 May;20(3):201-207. doi: 10.1016/j.cllc.2018.10.002. Epub 2018 Oct 11.

Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab.

Lung Cancer. 2018 Jan;115:71-74. doi: 10.1016/j.lungcan.2017.11.019. Epub 2017 Nov 21.

引用本文的文献

Real-world data of cadonilimab in recurrent or metastatic cervical cancer in China: a multicentric study.

Front Immunol. 2025 Jul 14;16:1611696. doi: 10.3389/fimmu.2025.1611696. eCollection 2025.

Risk of Rash in PD-1 or PD-L1-Related Cancer Clinical Trials: A Systematic Review and Meta-Analysis.

J Oncol. 2022 Jul 18;2022:4976032. doi: 10.1155/2022/4976032. eCollection 2022.

Clinical Characteristics and Mathematical Analysis of Curative Effect of Hemodialysis in Curing Poisoning Caused by Snakebite.

Scanning. 2022 May 6;2022:2312972. doi: 10.1155/2022/2312972. eCollection 2022.

Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy.

Front Endocrinol (Lausanne). 2022 Mar 22;13:779915. doi: 10.3389/fendo.2022.779915. eCollection 2022.

Organ-Specific Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Monotherapy Versus Combination Therapy in Cancer: A Meta-Analysis of Randomized Controlled Trials.

Front Pharmacol. 2020 Jan 30;10:1671. doi: 10.3389/fphar.2019.01671. eCollection 2019.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Immune-Related Adverse Events (irAEs) Predict for Clinical Efficacy: Focusing on Organ-Specific irAEs and the Critical Role of Steroids.

作者信息

Yang Xu, Lin Jianzhen, Wang Dongxu, Zhang Li, Zhao Haitao

机构信息

Department of Liver Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

Department of Respiratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

出版信息

J Thorac Oncol. 2019 Oct;14(10):e233-e234. doi: 10.1016/j.jtho.2019.05.020.

DOI:10.1016/j.jtho.2019.05.020

PMID:31558237

Abstract

摘要

相似文献

J Thorac Oncol. 2019 Oct;14(10):e233-e234. doi: 10.1016/j.jtho.2019.05.020.

In Response to the Letter by Dr. Yang et al, Immune-Related Adverse Events (irAEs) Predict for Clinical Efficacy: Forcing on Organ-Specific irAEs and the Critical Role of Steroids.

J Thorac Oncol. 2019 Nov;14(11):e260-e261. doi: 10.1016/j.jtho.2019.07.029.

BMC Cancer. 2019 Jun 10;19(1):558. doi: 10.1186/s12885-019-5701-6.

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients.

Clin Lung Cancer. 2019 Jul;20(4):237-247.e1. doi: 10.1016/j.cllc.2019.02.006. Epub 2019 Feb 21.

Predictors of immunotherapy-induced immune-related adverse events.

Curr Oncol. 2018 Oct;25(5):e403-e410. doi: 10.3747/co.25.4047. Epub 2018 Oct 31.

Influenza vaccination in patients with lung cancer receiving anti-programmed death receptor 1 immunotherapy does not induce immune-related adverse events.

Eur J Cancer. 2018 Nov;104:182-187. doi: 10.1016/j.ejca.2018.09.012. Epub 2018 Oct 24.

J Thorac Oncol. 2017 Dec;12(12):1798-1805. doi: 10.1016/j.jtho.2017.08.022. Epub 2017 Sep 20.

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study.

Lancet Haematol. 2019 Jan;6(1):e48-e57. doi: 10.1016/S2352-3026(18)30175-3. Epub 2018 Dec 4.

Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer.

Clin Lung Cancer. 2019 May;20(3):201-207. doi: 10.1016/j.cllc.2018.10.002. Epub 2018 Oct 11.

Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab.

Lung Cancer. 2018 Jan;115:71-74. doi: 10.1016/j.lungcan.2017.11.019. Epub 2017 Nov 21.

引用本文的文献

Real-world data of cadonilimab in recurrent or metastatic cervical cancer in China: a multicentric study.

Front Immunol. 2025 Jul 14;16:1611696. doi: 10.3389/fimmu.2025.1611696. eCollection 2025.

Risk of Rash in PD-1 or PD-L1-Related Cancer Clinical Trials: A Systematic Review and Meta-Analysis.

J Oncol. 2022 Jul 18;2022:4976032. doi: 10.1155/2022/4976032. eCollection 2022.

Clinical Characteristics and Mathematical Analysis of Curative Effect of Hemodialysis in Curing Poisoning Caused by Snakebite.

Scanning. 2022 May 6;2022:2312972. doi: 10.1155/2022/2312972. eCollection 2022.

Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy.

Front Endocrinol (Lausanne). 2022 Mar 22;13:779915. doi: 10.3389/fendo.2022.779915. eCollection 2022.

Organ-Specific Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Monotherapy Versus Combination Therapy in Cancer: A Meta-Analysis of Randomized Controlled Trials.

Front Pharmacol. 2020 Jan 30;10:1671. doi: 10.3389/fphar.2019.01671. eCollection 2019.

Immune-Related Adverse Events (irAEs) Predict for Clinical Efficacy: Focusing on Organ-Specific irAEs and the Critical Role of Steroids.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Immune-Related Adverse Events (irAEs) Predict for Clinical Efficacy: Focusing on Organ-Specific irAEs and the Critical Role of Steroids.

作者信息

机构信息

出版信息

相似文献

引用本文的文献